ArticleBreast cancer research and treatment2026

Comment on: "Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors".

Sangameshwar Manikya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.